5093 | Humans |
3037 | Female |
2824 | Male |
1542 | Middle Aged |
1487 | Adult |
1302 | Animals |
1161 | Aged |
686 | Adolescent |
657 | Young Adult |
576 | Treatment Outcome |
517 | United States |
484 | Aged, 80 and over |
474 | Retrospective Studies |
473 | Child |
460 | Mice |
420 | Risk Factors |
314 | Time Factors |
305 | Prospective Studies |
305 | Follow-Up Studies |
253 | Magnetic Resonance Imaging |
247 | Cohort Studies |
234 | Child, Preschool |
218 | Surveys and Questionnaires |
215 | Signal Transduction |
200 | Prognosis |
195 | Reproducibility of Results |
190 | Disease Models, Animal |
184 | Infant |
182 | Pregnancy |
180 | Rats |
178 | Brain |
172 | Cross-Sectional Studies |
170 | Age Factors |
167 | Biomarkers |
162 | Case-Control Studies |
161 | Mice, Inbred C57BL |
154 | Cell Line, Tumor |
150 | Cells, Cultured |
149 | Severity of Illness Index |
145 | Pennsylvania |
140 | Mutation |
135 | Tomography, X-Ray Computed |
135 | Longitudinal Studies |
134 | Risk Assessment |
132 | Rats, Sprague-Dawley |
129 | Incidence |
128 | Algorithms |
122 | Predictive Value of Tests |
122 | Depression |
118 | Cell Proliferation |
117 | Infant, Newborn |
115 | Breast Neoplasms |
112 | Phenotype |
110 | HIV Infections |
110 | Cell Line |
109 | Aging |
108 | Apoptosis |
104 | Antineoplastic Agents |
103 | Quality of Life |
101 | Sensitivity and Specificity |
100 | Survival Rate |
100 | Mice, Knockout |
100 | Body Mass Index |
99 | Obesity |
99 | Genotype |
98 | Neoplasms |
98 | Logistic Models |
97 | Postoperative Complications |
96 | Computer Simulation |
95 | Smoking |
95 | Genetic Predisposition to Disease |
94 | Protein Binding |
94 | Inflammation |
93 | Polymorphism, Single Nucleotide |
93 | Biomarkers, Tumor |
92 | Neurons |
89 | Comorbidity |
88 | Immunohistochemistry |
87 | Prevalence |
86 | Models, Biological |
82 | Sex Factors |
82 | Neoplasm Staging |
81 | Cell Differentiation |
80 | Neuropsychological Tests |
80 | Molecular Sequence Data |
80 | European Continental Ancestry Group |
80 | Disease Progression |
80 | Cognition |
78 | Models, Molecular |
76 | Mice, Transgenic |
73 | Lung |
73 | Gene Expression Regulation |
73 | Dose-Response Relationship, Drug |
73 | Anti-Bacterial Agents |
71 | Multivariate Analysis |
71 | Diagnosis, Differential |
70 | Kaplan-Meier Estimate |
70 | Cytokines |
68 | Equipment Design |
67 | Lung Neoplasms |
67 | Cardiovascular Diseases |
67 | Biomechanical Phenomena |
66 | Proportional Hazards Models |
66 | Databases, Factual |
64 | African Americans |
63 | Motor Activity |
63 | Image Processing, Computer-Assisted |
63 | Antineoplastic Combined Chemotherapy Protocols |
62 | Amino Acid Sequence |
61 | Survival Analysis |
61 | Stroke |
61 | Double-Blind Method |
61 | Decision Making |
61 | Carcinoma, Squamous Cell |
61 | Blood Pressure |
60 | Combined Modality Therapy |
59 | RNA, Messenger |
59 | Pilot Projects |
59 | Liver |
58 | Randomized Controlled Trials as Topic |
58 | Practice Guidelines as Topic |
58 | Heart Failure |
58 | Depressive Disorder, Major |
58 | Cognition Disorders |
57 | Risk |
57 | Psychiatric Status Rating Scales |
57 | Diabetes Mellitus, Type 2 |
57 | Brain Injuries |
56 | Stress, Psychological |
56 | Phosphorylation |
56 | Neoplasm Recurrence, Local |
56 | Gene Expression |
56 | Disease-Free Survival |
55 | Intensive Care Units |
55 | Gene Expression Profiling |
54 | Substance-Related Disorders |
54 | Socioeconomic Factors |
54 | Radiography |
54 | Linear Models |
54 | Cell Survival |
54 | Asthma |
53 | Self Report |
53 | Registries |
53 | Models, Theoretical |
53 | Genome-Wide Association Study |
53 | Brain Mapping |
53 | Biopsy |
53 | Adenocarcinoma |
52 | Alzheimer Disease |
51 | Recurrence |
51 | Odds Ratio |
51 | HIV-1 |
51 | Gene Expression Regulation, Neoplastic |
51 | Clinical Trials as Topic |
51 | Analysis of Variance |
50 | Positron-Emission Tomography |
50 | Outcome Assessment (Health Care) |
50 | Mitochondria |
50 | Macrophages |
50 | HEK293 Cells |
49 | Psychometrics |
49 | Length of Stay |
49 | Kinetics |
49 | Kidney |
49 | Emotions |
49 | Acute Disease |
48 | Muscle, Skeletal |
48 | Head and Neck Neoplasms |
48 | Base Sequence |
47 | Models, Statistical |
47 | Membrane Proteins |
47 | Hypertension |
47 | Cell Movement |
47 | Bipolar Disorder |
46 | Sleep |
46 | Skin Neoplasms |
46 | Schizophrenia |
46 | ROC Curve |
46 | Prefrontal Cortex |
45 | Weight Loss |
45 | Transcription Factors |
45 | Patient Satisfaction |
45 | Hospitalization |
45 | Evidence-Based Medicine |
45 | Chronic Disease |
44 | Pain Measurement |
44 | Health Knowledge, Attitudes, Practice |
44 | Extracellular Matrix |
44 | Emergency Service, Hospital |
44 | Anxiety |
44 | Alleles |
43 | Software |
43 | Mice, Inbred BALB C |
43 | Interpersonal Relations |
43 | Exercise |
42 | Regression Analysis |
42 | Neural Pathways |
42 | Macaca mulatta |
42 | Feasibility Studies |
41 | Protein Structure, Tertiary |
40 | Urinary Bladder |
40 | Up-Regulation |
40 | Tissue Scaffolds |
40 | Tissue Engineering |
40 | Swine |
40 | Sequence Analysis, DNA |
40 | Reaction Time |
40 | RNA Interference |
40 | Primary Health Care |
40 | Patient Selection |
40 | Pancreatic Neoplasms |
40 | Mental Disorders |
40 | Knee Joint |
40 | Hepatocytes |
40 | Blotting, Western |
40 | Adolescent Behavior |
39 | Sepsis |
39 | Promoter Regions, Genetic |
39 | Oxygen |
39 | Oxidative Stress |
39 | Melanoma |
39 | Internet |
39 | Depressive Disorder |
39 | DNA |
39 | Activities of Daily Living |
38 | Reoperation |
38 | Proteins |
38 | Imaging, Three-Dimensional |
38 | Epithelial Cells |
38 | Cognitive Therapy |
38 | Alcohol Drinking |
38 | Adaptation, Psychological |
37 | Real-Time Polymerase Chain Reaction |
37 | Microscopy, Fluorescence |
37 | Gait |
37 | Drug Therapy, Combination |
37 | Cost-Benefit Analysis |
37 | Anti-HIV Agents |
37 | Action Potentials |
36 | Societies, Medical |
36 | Research Design |
36 | Peptides |
36 | Parents |
36 | Pain |
36 | Mice, Nude |
36 | Graft Rejection |
36 | Genetic Variation |
36 | Dendritic Cells |
36 | Critical Illness |
36 | Communication |
36 | Biocompatible Materials |
35 | Ultrasonography |
35 | Practice Patterns, Physicians' |
35 | Patient Education as Topic |
35 | Oxidation-Reduction |
35 | Laparoscopy |
35 | Internship and Residency |
35 | Cerebral Cortex |
35 | CD4-Positive T-Lymphocytes |
35 | Brain Ischemia |
34 | Women's Health |
34 | Walking |
34 | Protein Conformation |
34 | Prostatic Neoplasms |
34 | Polymers |
34 | Liver Neoplasms |
34 | Immunosuppressive Agents |
34 | Graft Survival |
34 | Ethnic Groups |
34 | Blood Glucose |
34 | Bacterial Proteins |
34 | Autophagy |
33 | Stem Cells |
33 | Recovery of Function |
33 | Reconstructive Surgical Procedures |
33 | Protein Transport |
33 | Hemodynamics |
33 | Health Status |
33 | Critical Care |
33 | Biomedical Research |
33 | Antibodies, Monoclonal |
33 | Antibodies, Monoclonal, Humanized |
32 | Quality of Health Care |
32 | Physicians |
32 | Phylogeny |
32 | Interleukin-6 |
32 | Immunity, Innate |
32 | Health Promotion |
32 | Health Behavior |
32 | Electroencephalography |
32 | Electrocardiography |
32 | Data Collection |
32 | DNA-Binding Proteins |
31 | Transcription, Genetic |
31 | RNA, Small Interfering |
31 | Neoplasm Invasiveness |
31 | Hippocampus |
31 | Forecasting |
31 | Executive Function |
31 | DNA Mutational Analysis |
31 | Clinical Competence |
31 | Cell Membrane |
31 | Binding Sites |
31 | Analgesics, Opioid |
30 | Transfection |
30 | Polymerase Chain Reaction |
30 | Photic Stimulation |
30 | Microbial Sensitivity Tests |
30 | MicroRNAs |
30 | Materials Testing |
30 | Lymph Nodes |
30 | Lung Transplantation |
30 | Life Style |
30 | Hospital Mortality |
30 | Enzyme-Linked Immunosorbent Assay |
30 | Diet |
30 | Computational Biology |
30 | Colorectal Neoplasms |
30 | Anterior Cruciate Ligament |
30 | Anterior Cruciate Ligament Reconstruction |
29 | Reward |
29 | Radiosurgery |
29 | Parent-Child Relations |
29 | Neoplasm Metastasis |
29 | Molecular Targeted Therapy |
29 | Models, Neurological |
29 | Microscopy, Confocal |
29 | Hypertension, Pulmonary |
29 | Drug Administration Schedule |
29 | Dementia |
29 | DNA Damage |
29 | Brain Neoplasms |
29 | Attitude of Health Personnel |
28 | Virus Replication |
28 | Uterine Cervical Neoplasms |
28 | User-Computer Interface |
28 | Tumor Necrosis Factor-alpha |
28 | Robotics |
28 | Reactive Oxygen Species |
28 | Range of Motion, Articular |
28 | Psychomotor Performance |
28 | Patient Compliance |
28 | Nitric Oxide |
28 | Molecular Dynamics Simulation |
28 | Mass Screening |
28 | Flow Cytometry |
28 | Cell Nucleus |
28 | Carcinoma, Non-Small-Cell Lung |
28 | Bariatric Surgery |
28 | Antidepressive Agents |
28 | Acute Kidney Injury |
27 | Temperature |
27 | Social Support |
27 | Smoking Cessation |
27 | Skin |
27 | Quality Improvement |
27 | Pregnancy Complications |
27 | Pediatrics |
27 | Liver Transplantation |
27 | Electronic Health Records |
27 | Drug Discovery |
27 | Diagnostic Imaging |
27 | Diabetes Mellitus |
27 | Continental Population Groups |
27 | Calcium |
27 | Body Weight |
27 | Area Under Curve |
27 | Age of Onset |
26 | T-Lymphocytes |
26 | Respiration, Artificial |
26 | Recombinant Proteins |
26 | Ovarian Neoplasms |
26 | Mesenchymal Stromal Cells |
26 | Kidney Transplantation |
26 | Influenza, Human |
26 | Hispanic Americans |
26 | Heart Arrest |
26 | Green Fluorescent Proteins |
26 | Glucose |
26 | Gene Expression Regulation, Developmental |
26 | Fibroblasts |
26 | Escherichia coli |
26 | Endothelial Cells |
26 | Diabetes Mellitus, Type 1 |
26 | Delivery of Health Care |
26 | Cell Death |
26 | Antipsychotic Agents |
25 | Translational Medical Research |
25 | Thermodynamics |
25 | Stress, Mechanical |
25 | Social Behavior |
25 | Sleep Wake Disorders |
25 | Reference Values |
25 | Receptor, Epidermal Growth Factor |
25 | Drug Resistance, Neoplasm |
25 | Drug Delivery Systems |
25 | Disabled Persons |
25 | Data Interpretation, Statistical |
25 | Contrast Media |
25 | Cognitive Dysfunction |
25 | Chi-Square Distribution |
25 | Chemotherapy, Adjuvant |
25 | Caregivers |
25 | Attention |
25 | Anxiety Disorders |
25 | Anticoagulants |
25 | Affect |
24 | White Matter |
24 | Weight Gain |
24 | Vascular Endothelial Growth Factor A |
24 | Surface Properties |
24 | Renal Dialysis |
24 | Premature Birth |
24 | Polymorphism, Genetic |
24 | Obesity, Morbid |
24 | Nerve Tissue Proteins |
24 | Nerve Net |
24 | Motivation |
24 | Molecular Structure |
24 | Insulin Resistance |
24 | Inflammation Mediators |
24 | Hydrogen-Ion Concentration |
24 | Genomics |
24 | Energy Metabolism |
24 | Early Detection of Cancer |
24 | Disability Evaluation |
24 | Cooperative Behavior |
24 | Chronic Pain |
24 | CD8-Positive T-Lymphocytes |
24 | Antihypertensive Agents |
23 | Water |
23 | Transplantation, Homologous |
23 | Structure-Activity Relationship |
23 | Spinal Cord Injuries |
23 | Single-Blind Method |
23 | Papillomavirus Infections |
23 | Organ Size |
23 | NF-kappa B |
23 | Mothers |
23 | Models, Psychological |
23 | Hypoglycemic Agents |
23 | Host-Pathogen Interactions |
23 | Health Care Surveys |
23 | HeLa Cells |
23 | Glomerular Filtration Rate |
23 | Geriatric Assessment |
23 | Genetic Association Studies |
23 | Gene Regulatory Networks |
23 | Family |
23 | Factor Analysis, Statistical |
23 | Endovascular Procedures |
23 | Emergency Medical Services |
23 | Echocardiography |
23 | Diffusion Tensor Imaging |
23 | Curriculum |
23 | Cluster Analysis |
23 | Canada |
23 | Asian Continental Ancestry Group |
23 | Administration, Oral |
22 | Wound Healing |
22 | Vitamin D |
22 | Treatment Failure |
22 | Statistics as Topic |
22 | Reverse Transcriptase Polymerase Chain Reaction |
22 | Renal Insufficiency, Chronic |
22 | Referral and Consultation |
22 | Psychotherapy |
22 | Proteomics |
22 | Protein Kinase Inhibitors |
22 | Pre-Eclampsia |
22 | Physician-Patient Relations |
22 | Myocardial Infarction |
22 | Medication Adherence |
22 | Ligands |
22 | Injury Severity Score |
22 | Image Interpretation, Computer-Assisted |
22 | Health Services Accessibility |
22 | Gene Knockdown Techniques |
22 | Fluorescent Dyes |
22 | Enzyme Activation |
22 | Dietary Supplements |
22 | Corpus Striatum |
22 | Coronary Artery Disease |
22 | Child Development |
22 | Cerebrovascular Circulation |
22 | Carrier Proteins |
22 | Calibration |
22 | Behavior Therapy |
22 | Animals, Genetically Modified |
22 | Academic Medical Centers |
21 | Xenograft Model Antitumor Assays |
21 | Wounds and Injuries |
21 | Transplantation, Heterologous |
21 | Survivors |
21 | Stroke Volume |
21 | Stress Disorders, Post-Traumatic |
21 | Species Specificity |
21 | Sleep Initiation and Maintenance Disorders |
21 | Qualitative Research |
21 | Proto-Oncogene Proteins |